Myriad Genetics
(NASDAQ) MYGN
Myriad Genetics Financials at a Glance
Market Cap
$360.79M
Revenue (TTM)
$829.00M
Net Income (TTM)
$399.90M
EPS (TTM)
$-4.32
P/E Ratio
-0.89
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$3.81
Volume
1,034,572.65
Open
$3.88
Price
$3.81
Volume
1,034,572.65
Open
$3.88
Previous Close
$3.82
Daily Range
$3.77 - $3.95
52-Week Range
$3.53 - $8.59
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$3.81
Volume
1,034,572.65
Open
$3.88
Previous Close
$3.82
Daily Range
$3.77 - $3.95
52-Week Range
$3.53 - $8.59
MYGN News
MYGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Myriad Genetics
Industry
Biotechnology
Sector
Health CareEmployees
2,700
CEO
Samraat S Raha, MBA
Website
www.myriad.comHeadquarters
Salt Lake City, UT 84108, US
MYGN Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
-46%
Net Income Margin
-48%
Return on Equity
-77%
Return on Capital
-71%
Return on Assets
-59%
Earnings Yield
-1.12%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$360.79M
Shares Outstanding
94.45M
Volume
1.03M
Avg. Volume
1.94M
Financials (TTM)
Gross Profit
$576.60M
Operating Income
$67.80M
EBITDA
$330.90M
Operating Cash Flow
$1.80M
Capital Expenditure
$15.60M
Free Cash Flow
$13.80M
Cash & ST Invst.
$149.60M
Total Debt
$209.80M
Myriad Genetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$200.40M
+2.3%
Gross Profit
$137.60M
+2.5%
Gross Margin
68.66%
N/A
Market Cap
$360.79M
N/A
Market Cap/Employee
$133.63K
N/A
Employees
2,700
N/A
Net Income
$34.10M
-34000.0%
EBITDA
$17.50M
-23.2%
Quarterly Fundamentals
Net Cash
$87.10M
-32.4%
Accounts Receivable
$123.80M
+2.8%
Inventory
$27.90M
-1.4%
Long Term Debt
$204.40M
+39.3%
Short Term Debt
$7.10M
-34.9%
Return on Assets
-59.36%
N/A
Return on Invested Capital
-70.56%
N/A
Free Cash Flow
$21.10M
+14.2%
Operating Cash Flow
$15.70M
+3.7%